HEMATOLOGICAL DYSFUNCTIONS: DEEP VENOUS THROMBOSIS IN SYNDROME INFECTIOUS CAUSED BY COVID-19
COVID-19, Renal insufficiency, Venous thrombosis, Thrombocytopenia
Introduction: The novel coronavirus disease (COVID-19) was responsible for the increase mainly in the number of cases of hospitalized patients in a state of hypercoagulability and other hematological changes, having as a problem of deep vein thrombosis (DVT), in the intensive care unit (ICU). Objective: to present an analysis of the infectious process and incidence of Deep Vein Thrombosis in patients diagnosed with COVID-19, in addition to promoting criteria for early identification and detection of risks for clot formation. Methodology: this is a retrospective study carried out by analyzing the electronic medical records of 26 patients of patients with COVID-19 in the period between February and May 2021. patients with COVID19P and 10 patients with COVID-19 without the presence of DVT. Results: DVT was present in 61.54% of the patients evaluated with COVID-19, the age group ranged mainly between 40 and 59 years and males were prevalent in both groups. Regarding comorbidities, systemic arterial hypertension was present in 75% of patients who developed DVT, followed by obesity and diabetes mellitus. All patients evaluated in both groups had increased levels of CRP, ferritin and D-dimer. In the cogulogram, TAP and APTT showed alterations only in the group that corresponds to those who developed DVT. Conclusion: Thrombocytopenia was correlated with progression of COVID19 and development of DVT. The need for mechanical ventilation, the use of arterial and venous devices, the period of hospitalization, and the development of acute kidney injury requiring hemodialysis, demonstrated the impact that DVT has on hospitalized patients and its imminent increase in the risk of mortality when associated with COVID-19. Statistically, patients with COVID-19 associated with DVT are more likely to develop a severe clinical condition